SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/308947"
 

Search: id:"swepub:oai:gup.ub.gu.se/308947" > Bridging The Age Ga...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ring, A. (author)

Bridging The Age Gap: observational cohort study of effects of chemotherapy and trastuzumab on recurrence, survival and quality of life in older women with early breast cancer

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-05-10
  • Springer Science and Business Media LLC,2021

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/308947
  • https://gup.ub.gu.se/publication/308947URI
  • https://doi.org/10.1038/s41416-021-01388-9DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Chemotherapy improves outcomes for high risk early breast cancer (EBC) patients but is infrequently offered to older individuals. This study determined if there are fit older patients with high-risk disease who may benefit from chemotherapy. Methods: A multicentre, prospective, observational study was performed to determine chemotherapy (±trastuzumab) usage and survival and quality-of-life outcomes in EBC patients aged ≥70 years. Propensity score-matching adjusted for variation in baseline age, fitness and tumour stage. Results: Three thousands four hundred sixteen women were recruited from 56 UK centres between 2013 and 2018. Two thousands eight hundred eleven (82%) had surgery. 1520/2811 (54%) had high-risk EBC and 2059/2811 (73%) were fit. Chemotherapy was given to 306/1100 (27.8%) fit patients with high-risk EBC. Unmatched comparison of chemotherapy versus no chemotherapy demonstrated reduced metastatic recurrence risk in high-risk patients(hazard ratio [HR] 0.36 [95% CI 0.19–0.68]) and in 541 age, stage and fitness-matched patients(adjusted HR 0.43 [95% CI 0.20–0.92]) but no benefit to overall survival (OS) or breast cancer-specific survival (BCSS) in either group. Chemotherapy improved survival in women with oestrogen receptor (ER)-negative cancer (OS: HR 0.20 [95% CI 0.08–0.49];BCSS: HR 0.12 [95% CI 0.03–0.44]).Transient negative quality-of-life impacts were observed. Conclusions: Chemotherapy was associated with reduced risk of metastatic recurrence, but survival benefits were only seen in patients with ER-negative cancer. Quality-of-life impacts were significant but transient. Trial Registration: ISRCTN 46099296. © 2021, The Author(s).

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Battisti, N. M. L. (author)
  • Reed, M. W. R. (author)
  • Herbert, E. (author)
  • Morgan, J. L. (author)
  • Bradburn, M. (author)
  • Walters, S. J. (author)
  • Collins, K. A. (author)
  • Ward, S. E. (author)
  • Holmes, G. R. (author)
  • Burton, M. (author)
  • Lifford, K. (author)
  • Edwards, A. (author)
  • Robinson, T. G. (author)
  • Martin, C. (author)
  • Chater, T. (author)
  • Pemberton, K. J. (author)
  • Brennan, A. (author)
  • Cheung, K. L. (author)
  • Todd, A. (author)
  • Audisio, Riccardo AGothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för kirurgi,Institute of Clinical Sciences, Department of Surgery(Swepub:gu)xaudri (author)
  • Wright, J. (author)
  • Simcock, R. (author)
  • Green, T. (author)
  • Revell, D. (author)
  • Gath, J. (author)
  • Horgan, K. (author)
  • Holcombe, C. (author)
  • Winter, M. C. (author)
  • Naik, J. (author)
  • Parmeshwar, R. (author)
  • Gosney, M. A. (author)
  • Hatton, M. Q. (author)
  • Thompson, A. M. (author)
  • Wyld, L. (author)
  • Collins, K. (author)
  • Ward, S. (author)
  • Holmes, G. (author)
  • Morgan, J. (author)
  • Bradburn, M. (author)
  • Walters, S. (author)
  • Burton, M. (author)
  • Lifford, K. (author)
  • Edwards, A. (author)
  • Brain, K. (author)
  • Ring, A. (author)
  • Robinson, T. (author)
  • Pemberton, K. (author)
  • Shrestha, A. (author)
  • Nettleship, A. (author)
  • Richards, P. (author)
  • Cheung, K. L. (author)
  • Harder, H. (author)
  • Audisio, R. (author)
  • Battisti, N. M. L. (author)
  • Wright, J. (author)
  • Simcock, R. (author)
  • Murray, C. (author)
  • Thomson, A. M. (author)
  • Gosney, M. (author)
  • Hatton, M. (author)
  • Armitage, F. (author)
  • Patnick, J. (author)
  • Green, T. (author)
  • Revill, D. (author)
  • Gath, J. (author)
  • Horgan, K. (author)
  • Holcombe, C. (author)
  • Winter, M. (author)
  • Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för kirurgi (creator_code:org_t)

Related titles

  • In:British Journal of Cancer: Springer Science and Business Media LLC125, s. 209-2190007-09201532-1827

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view